Asset Management Corp Novavax Inc Call Options Transaction History

Asset Management Corp

4 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q2 2022 Aug 01, 2022	SELL	$36.28 - $75.29 $108,840 - $225,870	-3,000 Closed	0 $0
Q1 2022 May 03, 2022	BUY	$69.73 - $142.9 $76,703 - $157,190	1,100 Added 57.89%	3,000 $221,000
Q4 2021 Jan 25, 2022	SELL	$134.56 - $217.97 $201,840 - $326,955	-1,500 Reduced 44.12%	1,900 $271,000
Q3 2021 Oct 13, 2021	BUY	$177.8 - $270.58 $604,520 - $919,972	3,400 New	3,400 $705,000

291

93.4M

6.95M

9.4M

Ticker NVAX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 78,215,104
Market Cap $704M
Description
Novavax, Inc., a biotechnology company, focuses on the discovery, development, and commercialization of vaccines to prevent serious infectious diseases and address health needs. The company's vaccine candidates include NVX-CoV2373, a coronavirus vaccine candidate that is in two Phase III trials, one Phase IIb trial, and one Phase I/II trial; Nan...

Get notified when there are updates to the investment portfolio of Asset Management Corp , based on Form 13F filings with the SEC.

Stay updated on Asset Management Corp with notifications on news.